Eli Kehrli

/Tag:Eli Kehrli

Bionaturis Group shows its premium solutions for human and animal health to the Bio International Convention 2016

The Bio International Convention 2016 once again will be an essential meeting point in the Bionaturis Group schedule. This event, considered the most important in the biotech sector worldwide, will be held on 6-9th of June in San Francisco (California).

Bionaturis Group is present at the Bio Convention 2016 after a year in which it has strengthened its positioning in the US market after the signing of a contract between Biobide and the US National Institute of Environmental Health (NIEHS), one of the most prestigious and demanding health institutions in the world. Biobide, the Bionaturis Group company that are experts in the use of the zebrafish model, also founded a subsidiary in Maryland in the same year.

In addition, Bionaturis will also highlight at the Bio Convention 2016 the new premium solutions in its portfolio which includes six new developments, five of which are for animal health.  These new developments point to several high-relevance diseases in livestock and pets, such as atopic dermatitis, osteoarthritis (or arthrosis) and different types of cancer. The global Animal Health sector represented an annual figure of $100 billion in 2014. In this area, drugs and vaccines reach until $23 billion (USD) with a CAGR of 6% for 2013-2017.

Bionaturis Group delegates in this edition are the chief scientific officer in Bionaturis, Juan J. Infante, the general Manager of Biobide, Andoni Cruz, and the Global Sales Manager in Bionaturis Group, Eli Kehrli. Biobide’s booth is in the Biobosque Region, inside the Spanish Pavillion (Booth 605). The applications of one-to-one meetings with Bionaturis Group delegates can be arranged emailing to eli.kehrli@bionaturis.com.

Consolidation and new contacts

The main goals of Bionaturis Group in this worldwide event are focused on the consolidation and monitoring of current customers and in […]

June 6th, 2016|Blog english, congress|Comments Off on Bionaturis Group shows its premium solutions for human and animal health to the Bio International Convention 2016

Bionaturis Group strengthens its bet on animal health

Bionaturis Group recently attended the 10th Anniversary commemorative event of the Kansas City Animal Health Corridor, which is quickly becoming one of the most important business investment events in the Animal Health world. The Global Sales Manager of Bionaturis Group, Eli Kehrli, joined the forum, which gathered 500 experts from this sector.

The Kansas City Corridor Investment Forum is an opportunity for experts in the field to gather ideas for future discussions about key market drivers, identifying the needs of the Investment and Development companies, and to present the newest technologies which will impact the sector in the years to come.  During the Kansas City Investment forum, Mr. Kehrli confirmed the business opportunities for the Bionaturis Group as a result of its capacity to offer alternative products for key diseases in the sector which currently have either an ineffective solution or lack a therapeutic altogether.

In addition to the market intelligence gathered, Bionaturis also focused on improving its current collaborations with key strategic partners in the US and abroad. “Bionaturis Group’s investment in Animal Health is clear and increasingly impactful. The proof of that is the expansion of the products for livestock, poultry, fishfarming and companion animals that we are developing, as well as the implementation of our international strategy in this sector and our presence in worldwide events as this one”, stated Mr. Kehrli.

Mr. Kehrli said, “as Bionaturis continues to build out its portfolio of biologics using innovative technology and a novel platform, it’s clear that we are better positioned each day to be the partner of choice in the Animal Health Sector. Our business model allows flexibility for our partners and increases our ability to provide value along multiple insertion points in the value chain.”

About Bionaturis […]

September 30th, 2015|Blog english, congress|Comments Off on Bionaturis Group strengthens its bet on animal health

Bionaturis Group, at the KC Animal Health Investment Forum

The Global Sales Manager at Bionaturis Group, Eli Kehrli, is attending today the commemorative event of the 10th Anniversary of the Kansas City-centered Animal Health Corridor.

The Kansas City-centered Animal Health Corridor is the biggest business and research center devoted to animal health in the world. More than 300 companies are located in this area, considered the “Sillicon Valley” in this sector. With our attendance to this relevant event, in which more than 1,000 experts in the sector are taking part, Bionaturis continues working and strengthening its international strategy.

Bionaturis Group has already presence in USA with the subsidiary of BBD BioPhenix in Maryland and the strategic agreement with Biological Mimetics (BMI) to jointly develop new vaccines for human and animal health applications.

About Bionaturis Group

The Bionaturis Group offers cutting-edge biotechnological drugs and services for human and animal health. Considered an international benchmark in the vaccines research, Bionaturis Group closed last exercise with an increase of sales of 73% and a positive EBITDA of 29% compared to the previous year. The biotechnological Group which envisages a global access to health is listed on the Spanish stock exchange for SMEs (ticker BNT).

For further information about the event

September 1st, 2015|Blog english, congress|Comments Off on Bionaturis Group, at the KC Animal Health Investment Forum

Bionaturis Group consolidates its international scope in 2015 Bio Convention

Bionaturis and BBD BioPhenix – the two companies that comprise the Bionaturis Group –  have solidified their international scope in the latest edition of the Bio Convention, held this year in Philadelphia and considered an annual landmark in the worldwide biotech sector. During the event, our delegates engaged in significant one-on-one meetings with current and future customers demonstrating the increasing interest in the Group.

Bionaturis Development Area Manager, Dr. Juan Jose Infante; BBD BioPhenix General Manager, Mr. Andoni Cruz; and the Global Sales Manager, Mr. Eli Kehrli, were the Group’s delegates at the most important global biotech event of the year which brings together more than 15,000 biotech companies from 65 different countries.

The main goals of Bionaturis were focused on the consolidation and monitoring of current customers and in establishing new contacts with future customers and partners. In human health, Bionaturis progressed in its collaboration with BMI, a strategic partner in the US, for the joint development and manufacture of a recently validated antiviral vaccine technology on the Groups expression platform, Flylife. In animal health, Bionaturis’ delegates, Dr. Infante and Mr. Kehrli, held bilateral meetings with the business development managers of the largest multinational vet companies that represented both current customers as well as potential future collaborators. During these meetings, they dealt with key issues for the licensing of products currently in Bionaturis’ portfolio.

According to Dr. Infante, “with a more and more complete portfolio, our potential partners can find in Bionaturis Group a wide variety of possibilities that positions Bionaturis Group as the perfect partner in the development of biological medicines for both human and animal health. Being conscious of the changing requirements of the market, our business model adapts perfectly to the needs of each […]

June 29th, 2015|Blog english, congress|Comments Off on Bionaturis Group consolidates its international scope in 2015 Bio Convention

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.